Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Tracubest

Approved

STANDARD

Tracubest

BioRx Pharma Labs., LLP🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 85da12d5818ba7a5
Company: BioRx Pharma Labs., LLP
Type: Standard

Approval Details

Approval Id: 85da12d5818ba7a5
Drug Approval Philippines Name: Tracubest
Product Name: Tracubest
Registration Number: DRP-7642-01
Brand Name: Tracubest
Generic Name: Atracurium besilate
Dosage Form: Solution for Injection (IV)
Dosage Strength: 10 mg/mL
Manufacturer: BioRx Pharma Labs., LLP
Importer: Ambica International Corporation
Distributor: AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date: 26 April 2024
Expiry Date: 08 October 2029
Pharmacologic Category: Muscle Relaxant
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

85da12d5818ba7a5

Type

Standard

Back to Philippines FDA Approvals

Tracubest - Philippines FDA Drug Approval Details